What is the difference between biological agents and traditional drugs in treating rheumatoid diseases?

Long-term recurrence of synovitis will lead to the destruction of cartilage and bones in joints, joint dysfunction and even disability.

Vasculitis involves all organs of the whole body, so it is also called rheumatoid disease.

The differences between biological agents for the treatment of rheumatoid arthritis and traditional drugs are mainly: different molecular weight, different production methods, different therapeutic pertinence and different therapeutic effects.

First of all, its molecular weight is different from that of chemical drugs used for small analysis. At present, the drugs we take orally, such as methotrexate and leflunomide, are all small molecular chemical drugs with single structure. Biological agents are usually biological macromolecules, that is, biological protein drugs.

In addition, the mode of production is also different. Traditional chemical drugs are mainly chemical synthesis, and biological agents are produced by using new biotechnology. Some microorganisms and bacteria mentioned just now may be used in the production process.

In addition, it also has the function of targeted therapy. Chemical drugs mainly regulate the proliferation of B cells and T cells through regulation, which may act on different links. Biological agents play a targeted therapeutic role against specific pathogenic factors, which may block the occurrence and development of diseases.

In addition, the therapeutic effect is more definite, because it is a specific pathogenic factor, so its therapeutic effect is more obvious than that of traditional drugs.

Mongolian medicine rheumatism hospital

Professional treatment of scapulohumeral periarthritis,

Mongolian medicine rheumatism hospital